Page last updated: 2024-09-03

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and loxiglumide

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with loxiglumide in 2 studies

Compound Research Comparison

Studies
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Trials
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Recent Studies (post-2010)
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Studies
(loxiglumide)
Trials
(loxiglumide)
Recent Studies (post-2010) (loxiglumide)
2605257549

Protein Interaction Comparison

ProteinTaxonomy1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50)loxiglumide (IC50)
Cholecystokinin receptor type AHomo sapiens (human)0.195

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, S; Inoue, T; Izumi, T; Koyama, T; Ohmori, T; Tsuchiya, K1
Izumi, T1

Other Studies

2 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and loxiglumide

ArticleYear
Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.
    European journal of pharmacology, 1996, Apr-04, Volume: 300, Issue:1-2

    Topics: Animals; Behavior, Animal; Conditioning, Operant; Fear; Hormone Antagonists; Male; Proglumide; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Stress, Physiological

1996
[Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1998, Volume: 73, Issue:5

    Topics: Animals; Anxiety; Biogenic Monoamines; Brain; Cholecystokinin; Disease Models, Animal; Hormone Antagonists; Male; Proglumide; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin

1998